Catyalyst Pharmaceutical (CPRX) Posts Q3 Loss of 6c/Share

Catyalyst Pharmaceutical (NASDAQ: CPRX) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Catyalyst Pharmaceutical (CPRX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
• Lumentum shares rise on analyst upgrades, AI demand outlook